title: Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
abstract: The active site of type A or B influenza virus neuraminidase is composed of 11 conserved residues that directly interact with the substrate, sialic acid. An aromatic benzene ring has been used to replace the pyranose of sialic acid in our design of novel neuraminidase inhibitors. A bis(hydroxymethyl)pyrrolidinone ring was constructed in place of the N-acetyl group on the sialic acid. The hydroxymethyl groups replace two active site water molecules, which resulted in the high affinity of the nanomolar inhibitors. However, these inhibitors have greater potency for type A influenza virus than for type B influenza virus. To resolve the differences, we determined the X-ray crystal structure of three benzoic acid substituted inhibitors bound to the active site of B/Lee/40 neuraminidase. The investigation of a hydrophobic aliphatic group and a hydrophilic guanidino group on the aromatic inhibitors shows changes in the interaction with the active site residue Glu275. The results provide an explanation for the difference in efficacy of these inhibitors against types A and B viruses, even though the 11 active site residues of the neuraminidase are conserved.
authors.affiliation: Center for Macromolecular Crystallography, Department of Microbiology, University of Alabama, Birmingham, AL 35294, USA.
authors.forename: J B
authors.initials: JB
authors.lastname: Finley
authors.forename: V R
authors.initials: VR
authors.lastname: Atigadda
authors.forename: F
authors.initials: F
authors.lastname: Duarte
authors.forename: J J
authors.initials: JJ
authors.lastname: Zhao
authors.forename: W J
authors.initials: WJ
authors.lastname: Brouillette
authors.forename: G M
authors.initials: GM
authors.lastname: Air
authors.forename: M
authors.initials: M
authors.lastname: Luo
mesh_terms: D019817:Benzoic Acid / Q000737:chemistry / Q000378:metabolism; D001665:Binding Sites; D017124:Conserved Sequence; D003460:Crystallization; D018360:Crystallography, X-Ray; D015195:Drug Design; D004583:Electrons; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000378:metabolism*; D006860:Hydrogen Bonding; D009980:Influenza A virus / Q000201:enzymology; D009981:Influenza B virus / Q000201:enzymology*; D020128:Inhibitory Concentration 50; D008958:Models, Molecular; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D019158:N-Acetylneuraminic Acid / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship; D014867:Water / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D014867:Water; D019817:Benzoic Acid; D009439:Neuraminidase; D019158:N-Acetylneuraminic Acid